Safety and pharmacokinetics of ralinepag, a novel oral prostacyclin receptor agonist

Safety and pharmacokinetics of ralinepag, a novel oral prostacyclin receptor agonist

Background: Ralinepag is an oral, potent, highly selective prostacyclin receptor agonist and is in development for pulmonary arterial hypertension. Ralinepag was formulated as an immediate-release (IR) capsule, later modified to an extended-release (XR) tablet to optimize administration for once-dai...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ali Ataya, MD, James C. Coons, PharmD, Natalie Patzlaff, PhD, Meredith Broderick, PharmD, Scott Seaman, PhD, Namita Sood, MD, M. Patricia George, MD, Murali M. Chakinala, MD
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Series:	JHLT Open
Subjects:	Hypertension Pulmonary/drug therapy Receptors Prostaglandin/agonists Pulmonaryarterial hypertension Ralinepag
Online Access:	http://www.sciencedirect.com/science/article/pii/S2950133425000655
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Parenteral prostacyclin utilization in patients with pulmonary arterial hypertension in the intermediate-risk strata: a retrospective chart review and cross-sectional survey
by: Anjali Vaidya, et al.
Published: (2024-11-01)

Peak steps to measure ‘‘capacity for activity’’: Actigraphy in the ADAPT registry with oral treprostinil
by: Daniel Lachant, DO, et al.
Published: (2025-05-01)

Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report
by: E. A. Rezukhina, et al.
Published: (2021-09-01)

Evaluating a Community Health Worker Training Program for Medication Adherence Support
by: Richard Segal, RPh, PhD, et al.
Published: (2025-06-01)

Pharmacists’ Knowledge of Abnormal Uterine Bleeding in Women on Anticoagulant Therapy: A French Survey
by: Sibylle Frerebeau PharmD, et al.
Published: (2025-06-01)

A primary care psychiatric pharmacist clinic for addressing hypertension and mental health disparities in black patients
by: Stephanie L. Hsia, PharmD, BCPP, MAEd, et al.
Published: (2025-08-01)

Profiling type I and II interferon responses reveals distinct subgroups of pediatric patients with autoinflammatory disorders
by: Anaïs Nombel, PharmD, et al.
Published: (2025-05-01)

Guanfacine for the management of the behavioral manifestations of delirium in older hospitalized adults
by: Kayla Garvey, PharmD, et al.
Published: (2025-06-01)

Evaluating the Efficacy and Safety of Direct Oral Anticoagulants Compared to Vitamin K Antagonists in Patients with Antiphospholipid Syndrome: Updated Systematic Review and Meta-Analysis
by: Lama Alfehaid PharmD, MME, et al.
Published: (2025-08-01)

Lost Rate Control and Tachycardia-Induced Cardiomyopathy as a Result of an Interaction Between Enzalutamide and Diltiazem
by: Adrian de Boer, PharmD, et al.
Published: (2025-07-01)

Real-world experiences and treatment patterns among congenital heart disease patients with associated pulmonary vascular disease: Results from a real-world survey in the United States
by: Jordan D. Awerbach, MD, MPH, et al.
Published: (2025-08-01)

Outcomes Associated with Time in Therapeutic Range for Patients Receiving Intravenous Unfractionated Heparin
by: Mujtaba Mahmud PharmD, et al.
Published: (2025-08-01)

Significance of Normal Lung Volume on Quantitative CT Imaging Analysis in Group 1 and Group 3 Pulmonary HypertensionTake-home Points
by: Tadasu Okaya, MD. PhD, et al.
Published: (2024-12-01)

Glucose transporter 1 in vascular smooth muscle cells is dispensable for abdominal aortic aneurysm induced by angiotensin II
by: Keiichi Torimoto, MD, PhD, et al.
Published: (2025-01-01)

Association Between Neighborhood-Level Social Vulnerability and Hypertension Outcomes
by: John E. Brush, Jr., MD, et al.
Published: (2025-08-01)

Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia
by: Abdulaali R. Almutairi PhD, et al.
Published: (2025-02-01)

Development of severe pre-capillary pulmonary hypertension 7 years after heart transplant
by: Ryo Takano, MD, et al.
Published: (2025-08-01)

A central arteriovenous fistula reduces systemic hypertension in a mouse model
by: Anand Brahmandam, MD, et al.
Published: (2024-01-01)

140 Impact of Amiodarone Exposure on Apixaban Pharmacokinetics in Hospitalized Patients
by: Samantha Kolowrat, BS, et al.
Published: (2025-05-01)

Motivators and Barriers for Pursuing Postgraduate Programs in Pharmacy Practice Among Pharmacy Interns in Saudi Arabia
by: Abdullah M. Alhammad PharmD, et al.
Published: (2025-08-01)

Similar quality of life after balloon pulmonary angioplasty or pulmonary endarterectomy for CTEPH
by: P. Smeele, MD, et al.
Published: (2025-05-01)

Targeted lipid nanoparticles to modulate blood-brain barrier transcytosis in acute ischemic stroke
by: Jia Nong, Ph.D., et al.
Published: (2025-07-01)

Clinical Performance and Safety of Cerviron® Vaginal Ovules in the Management of Symptomatic Cervical Lesions: A National, Multicentric Study
by: Izabella Petre, Ph.D, MD, et al.
Published: (2024-01-01)

Early prediction of hypertensive disorders of pregnancy toward preventive early interventionAJOG Global Reports at a Glance
by: Satoshi Mizuno, PhD, et al.
Published: (2024-11-01)

Effect of nitric oxide, prostacyclin, and thromboxane on the vasospastic action of hydrogen peroxide on human umbilical artery
by: Yuji Okatani, et al.
Published: (1997-06-01)

Implementation of mMINDS monitoring for alcohol withdrawal at an inpatient academic psychiatric facility
by: Leah A. Surbaugh, PharmD, BCPP, et al.
Published: (2025-08-01)

Association Between Fixed-Dose Combination Use and Medication Adherence, Health Care Utilization, and Costs Among Medicaid Beneficiaries
by: Donglan Zhang, PhD, et al.
Published: (2025-09-01)

Using machine learning to predict the risk of developing hypertensive disorders of pregnancy using a contemporary nulliparous cohortAJOG Global Reports at a Glance
by: Jonathan S. Schor, PhD, et al.
Published: (2024-11-01)

Incidence and Risk Factors of De Novo Postpartum Hypertension
by: Ukachi N. Emeruwa, MD, MPH, et al.
Published: (2025-06-01)

Memantine leading to physical aggression in the treatment of chronic catatonia secondary to schizophrenia: A case report
by: Andrew Chantha Hean, PharmD, et al.
Published: (2025-08-01)

Developing personas to examine older adult engagement with televised direct-to-consumer advertisements: A theory based approach
by: Emily L. Hoffins, MS, et al.
Published: (2025-06-01)

Reply
by: Denis Vincent, MD, PhD, et al.
Published: (2025-05-01)

The Concomitant Therapy of Direct Oral Anticoagulants with Amiodarone in Atrial Fibrillation: A Meta-analysis
by: Kazuhiko Kido PharmD, PhD, et al.
Published: (2025-06-01)

Outcome of Conservative Treatment of Odontoid Fractures in Elderly Patients Over 80 Years Old
by: Andrea Speldova MD, et al.
Published: (2025-01-01)

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?
by: D. V. Nebieridze, et al.
Published: (2015-12-01)

Predicting complications in hypertensive disorders of pregnancy: external validation of a prognostic model for adverse perinatal outcomesAJOG Global Reports at a Glance
by: Klaartje M. Olde Loohuis, MD, et al.
Published: (2025-05-01)

ERAS including minimal Narcotic Pain Management Is Successful After Heart Transplant and LVAD Implantation: A Single Center Review
by: Joseph Elder, PharmD BCPS, et al.
Published: (2025-08-01)

Evaluating the efficacy of blister packaging in improving medication adherence within psychiatry: A systematic literature review
by: Eric P. Borrelli, PhD, PharmD, MBA, et al.
Published: (2025-06-01)

Review of acamprosate pharmacokinetics and dosing strategies
by: Lauren Steil, PharmD, et al.
Published: (2025-04-01)

CANBERRA: A Phase II Randomized Clinical Trial to Test the Therapeutic Potential of Oral Vicasinabin in Diabetic Retinopathy
by: Beatriz G. Armendariz, PhD, et al.
Published: (2025-03-01)